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Abstract
This project involved the synthesis of N-hexanoyl chitosan or simply modified chitosan (MC)
stabilized iron oxide nanoparticles (MC-IOPs) and the biological evaluation of MC-IOPs. IOPs
containing MC were prepared using conventional methods, and the extent of cell uptake was
evaluated using mouse macrophages cell line (RAW cells). MC-IOPs were found to rapidly
associate with the RAW cells, and saturation was typically reached within the 24 h of incubation at
37°C. Nearly 8.53 ± 0.31 pg iron/cell were bound or internalized at saturation. From these results,
we conclude that MC-IOPs effectively deliver into RAW cells in vitro and we also hope MC-IOPs
can be used for MRI enhancing agents in biomedical fields.
Background
Magnetic particles ranging from the nanometer to
micrometer scale are being used in an increasing number
of medical applications. The important properties of mag-
netic particles for medical applications are nontoxicity,
biocompatibility, injectability, and high level accumula-
tion in the target tissue or organ; the most important
property among those mentioned above is nontoxicity.
Magnetic nanoparticles offer attractive and versatile appli-
cations in the field of biotechnology, such as DNA and
RNA separation, cell separation, drug delivery system
(DDS), magnetic resonance imaging (MRI), and hyper-
thermia [1-6]. For these applications, magnetic iron
oxides such as Fe3O4 or gamma-Fe2O3 are employed as a
magnetic phase because they are stable and harmless to
the living bodies. To make them bind to a biological
entity, their surfaces are usually modified with an appro-
priate compound such as polyethyleneglycol (PEG) or
streptavidin. Polymers like poly-L-lysine (PLL), poly eth-
ylene imide (PEI) and dextran, and recently chitosan [6]
has been used as a stabilizer (coating agent) for iron oxide
nanoparticles so as to improve the nanoparticle's biocom-
patibility and injectability. However, high-level accumu-
lation in the target tissue or organ and cytotoxicity; the
most important property of the nanoparticles is remains
to be intact.
More or less to improve limitations stated above, several
derivatives of chitosan have been proposed based on reac-
tions with the free amino groups. Our research group
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already investigated the hydrophobic modification of nat-
ural chitosan by using three different acyl chlorides (hex-
anoyl, octanoyl and myristoyl chloride) so as to improve
its aqueous solubility and subsequently used them for sta-
bilization of metalic nanoparticles [7-9]. In this paper, we
have selected the hexanoyl chloride modified chitosan
stabilized iron oxide nanoparticles (Nac-6-IOPs or simply
MC-IOPs) as a material of interest and demonstrated its
biomedical application like cellular labeling, and MRI
using mouse macrophages cell line (RAW cells).
Results and discussion
Synthesis and characterization of MC-IOPs
The chemical structure of the native and modified chi-
tosan is shown in Figure 1.
The procedure for synthesis of IOPs, modification process
of chitosan, and its detailed characterization was taken
from a previously published report [9]. Briefly, Figure 2
shows the fourier transforms infrared (FT-IR) spectra of
pure chitosan (a) MC (curve b), IOPs (curve c), and MC-
IOPs (curve d). IOPs exhibit strong bands in the low fre-
quency region below 800 cm-1 due to the oxide skeleton.
The characteristic bands of modified chitosan, amide I, II,
and III were shifted 1623, 1510 and 1464 cm-1 due to
interaction with IOPs. Shifting of such amide bands from
higher to lower energies indicates the attachment of IOPs
with MC through nitrogen atom [8,9]. In other regions,
the spectra of IOPs have weak bands. The spectrum is con-
sistent with magnetic (Fe3O4) and the signals associated
to the magnetite appear as broad features at 408.9, 571.5
and 584.5 cm-1 [4]. Figure 3 shows the X-ray diffraction
(XRD) pattern of IOPs matched with the magnetite
(Fe3O4) phase as compared to standard XRD patterns
reported elsewhere [5]. The sharp peaks which appeared
approximately 2θ = 30°, 35°, 43°, 53°, 57° and 62° were
due to Fe3O4 [1]. Figure 4 shows the transmission electron
microscopy (TEM) images of IOPs, and MC-IOPs parti-
cles. The morphology of IOPs (Figure 4a) was seen as clus-
tered type, which is the same morphology as reported
elsewhere [10]. After modifications, morphology of IOPs
was significantly dispersed with an average diameter 10
nm (average over 100 particles) (Figure 4b) in aqueous
medium at pH 7.4. The average size of IOPs with and
without MC was 10 and 40 nm, respectively (Figure 4a, b
and table 1). Figure 4c shows the selected area diffraction
(SAD) pattern of MC-IOPs, which is in exact/or in good
agreement with the XRD results. The ring type SAD pat-
tern consists of a cubic inverse spinal structure of magnet-
ite and it indicates good crystalinity of the MC-IOPs.
Figure 4d, high resolution transmission electron micros-
copy (HRTEM) images further support the interplaner dis-
tances of d = 2.94 Å which is very closed to the plane d220
= 2.97 Å of the magnetite phase in orientation. Taken
together, the results of XRD, TEM and HRTEM, show that
the synthesized MC-IOPs is highly crystalline as can be
found in the pure magnetite phase without phase trans-
formation after conjugation with MC, showing a success-
ful synthesis of magnetic MC-IOPs. The results of dynamic
light scattering (DLS) measurements showed a uni-model
size distribution of the nanoparticles. The average sizes of
the IOPs and MC-IOPs were 60 and100 nm, respectively,
(Table 1, DLS measurement). In contrast to TEM measure-
ment, DLS gave a significantly larger size in the case of
both particles. The reason behind this phenomenon is
obvious. The particle size measured by DLS technique is
larger than that observed by TEM due to the different
nature working function of the two instruments. Moreo-
Chemical structure of chitosan and modified chitosan Figure 1
Chemical structure of chitosan and modified chitosan.Journal of Nanobiotechnology 2008, 6:1 http://www.jnanobiotechnology.com/content/6/1/1
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ver, DLS methods differ from TEM in that it measured the
hydrodynamic particle size in the dispersion medium.
TEM images show the core particle size, without the con-
tribution from the MC; since the MC layer normally col-
lapses onto the IOPs surface when the dispersion medium
is evaporated prior to imaging. It is also obvious that the
thickness of the stabilizing layer (here MC), when col-
lapsed on the surface of the IOPs, is negligible. Therefore,
the difference in diameter measurements obtained by DLS
and those obtained by TEM is the size of the stabilizing
layer. However, this method is only valid for small parti-
cles (diameter < 200 nm), since the size of the stabilizing
layer on larger particles is small relative to the experimen-
tal error inherent in DLS measurements (± 4%).
Table 1 shows the ζ-potential of IOPs and MC-IOPs. The
polymer of MC being a polycation gives different +ve ζ-
potential depending on the pH of the media. The ζ-poten-
tial of the MC was decreased at pH 7.4 after incorporation
of IOPs. However, the ζ-potential of MC-IOPs (+20.21
mV) at physiological conditions (pH 7.4) is still accepta-
ble for magnetofection of mammalian cells.
Figure 5 shows the magnetic properties of magnetic nano-
particles (MC-IOPs). The synthesized MC-IOPs indicate a
superparamagnetic behaviour, as evidenced by zero coer-
civity and remanance on the magnetization loop. A satu-
ration magnetization of ~50 emu/g was determined for
the MC-IOPs which is relatively lower than that of the
bulk value of Fe3O4 (70 emu/g). The higher value of mag-
netization of MC-IOPs makes them very susceptible to
magnetic fields, and easily separates from the solid and
liquid phases.
Biocompatibility and cellular labeling of MC-IOPs
MTT assays were performed to evaluate the cytotoxicity
corresponding to the biocompatibility of the materials on
RAW cell. Figure 6 shows the representative data of cyto-
toxicities from three different experiments with increasing
concentration of the MC-IOPs. The MC-IOPs at low con-
centration (<10 mg/ml) showed relatively no significant
toxicity on the cells. The cell viabilities in the presence of
MC-IOPs suspension ranged between 97–120% of the
control in all experiments. At a maximum MC-IOPs con-
centration (>15 mg/ml), the mean cell viabilities of the
cell lines showed about 88–97% viability compared with
that of the control. Interestingly, even at high concentra-
tions of MC-IOPs up to 100 mg/ml, which is 9~12-fold
higher than the concentration required for high efficiency
of intravenous injection, MC-IOPs showed no obvious
negative effect on cell viability. This means that the cell
XRD pattern of (a) IOPs, (b) MC-IOPs showing only magnet- ite reflection Figure 3
XRD pattern of (a) IOPs, (b) MC-IOPs showing only magnet-
ite reflection.
Table 1: Physiochemical properties of IOPs and MC-IOPs
Sample Size (nm) Charge (mV) Size distribution
TEM DLS
IOPs (Pure) 40 60 -10 Large
MC-IOPs 10 100 +20.21 Narrow
FTIR spectra of (a) pure chitosan, (b) MC, (c) pure IOPs and  (d) MC-IOPs Figure 2
FTIR spectra of (a) pure chitosan, (b) MC, (c) pure IOPs and 
(d) MC-IOPs.Journal of Nanobiotechnology 2008, 6:1 http://www.jnanobiotechnology.com/content/6/1/1
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viability, after exposure to different concentrations of the
MC-IOPs assessed in RAW cells, apparently unaltered in
the entire test dosage range from 0.05 to 0.2 mg after the
4 h of exposure, as depicted in Figure 6. The probable rea-
son for high compatibility could be the highly biocompat-
ible natural polymer of 
chitosan.
Semiqantitative microscopic analysis showed that the
MC-IOPs were incorporated by RAW cells in a concentra-
tion and time dependent manner, Figure 7. At the low
concentration of the MC-IOPs, only few cells showed
TEM images of (a) pure IOPs, (b) MC-IOPs, (c) SAD pattern of MC-IOPs and (d) HRTEM image of MC-IOPs showing a 10 nm  size magnetite nanoparticle with highly polycrystalline nature Figure 4
TEM images of (a) pure IOPs, (b) MC-IOPs, (c) SAD pattern of MC-IOPs and (d) HRTEM image of MC-IOPs showing a 10 nm 
size magnetite nanoparticle with highly polycrystalline nature.Journal of Nanobiotechnology 2008, 6:1 http://www.jnanobiotechnology.com/content/6/1/1
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intracytoplasmatic Prussian blue positive particles, Figure
7A(b). At a high concentration of the MC-IOPs, virtually
all cells contained several Prusssian blue-stained, Figure
7A(c), and no cellular loss or damage was observed. What-
ever the MC-IOPs concentration, the RAW cells stated
internalize the MC-IOPs after 30 min, Figure 7A(b) and
7(c), inset and reached a plateau after 3~4 h, Figure 7A(c).
Furthermore, colorimetric quantitative method was used
to determine and confirm dose-dependent nanoparticle
internalization by observing the RAW cell microscopically
(Figure 7B). At our optimal experimental setting based on
the morphological observation (10~20 MC-IOPs for 2 h
incubation time, Figure 7A(b) and 7(c), the macrophages
RAW cells contained an average of 8.53 ± 0.31 pg (iron/
cell), Figure 7B. Similarly, Figure 7C demonstrates the side
scattering (SSC) distribution of cell shifted with increasing
concentration of the MC-IOPs, which means an increase
in granularity with increasing MC-IOPs concentration.
This finding is important because we suspect the phagocy-
tosed MC-IOPs became endosomes and thereby increased
the granularity found in flow cytometry. These results fur-
ther support the semiquantitative microscopic analysis
(Prussian blue-stained).
Magnetic resonance (MR) study of MC-IOPs
Figure 8a and 8c, illustrated the signal contrast enhance-
ment performance of the MC-IOPs incubated with RAW
cells evaluated in clicical MR imager. This typical array
image of the RAW cells, with a concentration gradient of
the MC-IOPs in an incubated media solution, is taken by
T2 MR sequence. Under T2 weighted pulse sequence eval-
uation, the signal of each cell pellet was measured as
shown in Figure 8a and 8b. The image was further con-
verted into signal intensity by the provided image analysis
tool for quantitative measurements. Figure 8c demon-
strated the signal difference between cells with and with-
out MC-IOPs incubation. These results clearly indicate
that the signal intensity gradually dropped in the iron
concentration above 0.1 mg/ml which was in good agree-
ment to the results reported elsewhere [11].
Conclusion
MC-IOPs synthesized by simple precipitation method
showed highly crystalline, superparamagnetic behavior. It
also displayed high stability, nontoxicity, enhancement of
MR images and the potential endocytose the macrophage
cell line. From above preliminary results, we conclude
that MC-IOPs could be a better candidate for MR contrast
medium.
Experimental methods
Materials
Iron (III) chloride hexahydrate (FeCl3 6H2O) pure granu-
lated, 99%, iron (II) chloride tetrahydrate (FeCl2 4H2O)
99+%, and ammonium hydroxide (14.8 M) were pur-
chased from Fisher Scientific (Pittsburgh, PA). Deionized
water purged with nitrogen gas was used in all the steps
involved in the synthesis and formulation of iron oxide
nanoparticles. Chitosan-100 [viscosity average molecular
weight, Mv = 1.3 × 106, degree of deacetylation (fraction
of free amino group) 78%] was purchased from Wako
Pure Chemical Industries, Ltd., Japan.
Synthesis of iron oxide nanoparticles (IOPs)
Aqueous solutions of 0.1 M Fe(III) (30 mL) and 0.1 M
Fe(II) (15 mL) were mixed, and 3 mL of 5 M ammonia
solution was added dropwise over 1 min while stirring on
a magnetic stir plate. The stirring continued for 20 min
Toxicity evaluation of MC-IOPs on RAW cells by MTT assay Figure 6
Toxicity evaluation of MC-IOPs on RAW cells by MTT assay. 
Different volume (50 ~200 µl) of the nanoparticles was used 
form the stock MC-IOPs (11.2 mg/ml).
Magnetisation curve of magnetite obtained by VSM at room  temperature Figure 5
Magnetisation curve of magnetite obtained by VSM at room 
temperature.Journal of Nanobiotechnology 2008, 6:1 http://www.jnanobiotechnology.com/content/6/1/1
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under a nitrogen-gas atmosphere. The particles obtained
were washed 3 times using ultracentrifugation (25000 × g
for 20 min at 4°C) with nitrogen purged water. The iron
oxide nanoparticle yield, determined by weighing of the
lyophilized sample of the preparation, was 304 mg.
Modification of chitosan (MC)
The modification process of chitosan was taken from a
previously described report [7-9]. Briefly, a mixture of chi-
tosan-100 (0.83 g) and 1.0% aqueous acetic acid (100 ml)
was stirred for 24 h to ensure total solubility. The pH was
adjusted to 7.0 by slow addition of 0.1 M of NaOH with
strong agitation, yielding gel slurry. After addition of 0.02
M of fatty acyl chloride (hexanoyl chloride, FW = 134.61,
d = 0.978 g/ml), the resultant solution was diluted 11
times with de-ionized water. After 6 h of continuous stir-
ring, the solution was neutralized (pH 6.8–7.0) by 0.1 M
of NaOH and precipitated with acetone. The precipitate,
collected by filtration, was washed at 50–60°C with an
excess of methanol and decanted. The washing was
repeated 4 times to eliminate free fatty acids. Finally, the
products were dried under vacuum for 3 days at room
temperature. The chemical structure of native and modi-
fied chitosan is shown in Figure 1.
(A) Internalozation of MC-IOPs in RAW cells Figure 7
(A) Internalozation of MC-IOPs in RAW cells. Cells were cultured with different volume of MC-IOPs (11.2 mg/ml). Cytospin 
slides were stained with Prussian blue (iron staining) for RAW cells; (a) control cells, (b) and (c) cells incubated with 10 and 20 
µl MC-IOPs for 5 h. Inset figure indicate the higher magnification and black arrow denote cell label with particles. Scale bars 
represent 10 µm. (B) Iron content in RAW cells. Cells were cultured with different concentration of MC-IONPs for 2 h, and 
incubated for 24 h with fresh medium. C, 1, 2 and 3 represent 0, 5, 10 and 20 µl of MC-IOPs from the stock 11.2 mg/ml, 
respectively). (C) Flow cytometry of RAW cells incubated with different concentrations of MC-IOPs as described in (A). The 
SSC signal (SSC-H) is increased with increased concentrations of MC-IOPs. Quantitative iron assessment was performed with 
a colorimetric method. Values are means of ± S.D. of iron content per single RAW cells (pg).
a b c
A
B C
a
b
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Stabilization of iron oxide nanoparticles (MC-IOPs)
Polymer (5.0 ml of 0.33% of N-hexanoyl chitosan solu-
tions or MC) was added to the dispersion of the nanopar-
ticles (100 mg) (the dispersion was cooled to room
temperature but not lyophilized) and stirred overnight in
a closed container to minimize exposure to atmospheric
oxygen to prevent oxidation of the IOPs. These particles
were washed with nitrogen purged water to remove solu-
ble salts and excess polymer. Particles were separated by
ultracentrifugation at 30000 rpm (Optima LE-80K, Beck-
man, Palo Alta, CA) using a fixed angle rotor (50.2 Ti) for
30 min at 10°C. The supernatant was discarded, and the
sediment was redispersed in 15 mL of triply distilled water
by sonication in a water-bath sonicator (FS- 30, Fisher Sci-
entific) for 10 min. The suspension was centrifuged as
above, and the sediment was washed three times with tri-
ply distilled water. Nanoparticles were resuspended in tri-
ply distilled water by sonication as above for 20 min and
centrifuged at 1000 rpm for 20 min at 7–11°C to remove
any large aggregates. The supernatant containing MC-
IOPs was collected and re-diluted in phosphate buffer at
pH 7.4.
Structural characterization of MC-IOPs
FT-IR spectra were recorded at RT using a Perkin-Elmer
spectrometer, model 2000. The FT-IR spectrometer was
linked to a personal computer loaded with the IRDM (IR
Data Manager) program to process the recorded spectra.
The specimens were pressed into small discs using a spec-
troscopically pure KBr matrix. FT-IR measurements were
checked by the X-ray diffraction of isolated precipitates.
XRD (APD-10, Philips, Netherlands) was performed to
identify the structure of the MC-IOPs using Cu K alpha
radiation (λ = 1.54056 Å) between 20° and 90° (2θ) at
27°C.
Particle size, morphology and ξ-potential analysis of MC-
IOPs
The size and morphology of IOPs and MC-IOPs were
observed by TEM (JEM-1230, JEOL, Japan) and HRTEM
(QUANTA 200F, FEI, USA). The sample for TEM analysis
was obtained by placing a drop of IOPs and MC-IOPs sus-
pension diluted by distilled water onto a copper grid with-
out any staining, and drying it in air at room temperature.
The average hydrodynamic diameter and the ξ-potential
of IOPs and MC-IOPs were determined by DLS and ELS
(Zetasizer ZEN 3600, Malvern, UK), respectively. All DLS
measurements were done with an angle detection of 90°
at 25°C after diluting the dispersion to an appropriate
volume with water. The results were the mean values of
two experiments using the same sample.
T2 weighted MR images of a representive RAW cells incubated with different volume of MC-IOPs (11.2 mg/ml) for 5 h, (a) lon- gitudinal section, (b) coronal section and (c) signal intensity of sample c to 3 (lane c~3; control, 50, 100 and 200 µl MC-IOPs,  respectively) Figure 8
T2 weighted MR images of a representive RAW cells incubated with different volume of MC-IOPs (11.2 mg/ml) for 5 h, (a) lon-
gitudinal section, (b) coronal section and (c) signal intensity of sample c to 3 (lane c~3; control, 50, 100 and 200 µl MC-IOPs, 
respectively).Journal of Nanobiotechnology 2008, 6:1 http://www.jnanobiotechnology.com/content/6/1/1
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Magnetic property of MC-IOPs
Magnetic measurement was done using a SQUID magne-
tometer (MPMSXL-7, Quantum Design, USA). Magnetiza-
tion curves were recorded for a suspension and solid
sample of MC-IOPs at 27°C with an applied magnetic
field up to 10,000 Oe.
Evaluation of cytotoxicity
Evaluation of the cytotoxicity was performed by the MTT
assay in RAW cells (mouse macrophases cell lines).
Briefly, RAW cells suspensions containing 1 × 104 cell/well
in DMEM containing 10% FBS were distributed in a 96-
well plates, and incubated in a humidified atmosphere
containing 5% CO2 at 37°C for 24 h [12,13]. The cytotox-
icity of MC-IOPs was evaluated in comparison with con-
trol cells. Cells were incubated for additional 24 h after
the addition of defined concentration of MC-IOPs. The
mixture was replaced with fresh medium containing 10%
FBS. Then, 20 µl of MTT solution (5 mg/ml in 1 × PBS)
were added to each well. The plate was incubated for an
additional 4 h at 37°C. Next, MTT-containing medium
was aspirated off and 150 µl of DMSO were added to dis-
solve the crystals formed by living cells. Absorbance was
measured at 490 nm, using a microplate reader (ELX 800;
BIO-TEK Instruments, Inc.). The cell viability (%) was cal-
culated according to the following equation:
Cell viability (%) = [OD 490(sample)/OD 490(control)] 
× 100
Cellular uptake of MC-IOPs
To test cell up take study, RAW cells were prepared and
incubated at a concentration of 1 × 106 cells/ml with 5, 10
and 20 µl MC-IOPs (11.2 mg/ml stock) for 2 h, then incu-
bated with fresh medium overnight. The cells were har-
vested and measured by flow cytometry using SSC signal.
Similarly harvested RAW cells were further used for Prus-
sain blue staining using K4 [Fe(CN)6] reagents. Iron deter-
mination was performed by colorimetric determination
method.
Magnetic resonance (MR) study of MC-IOPs
For MR study, MC-IONPs were incubated with RAW cells
at different concentration for 24 h. The cells were har-
vested and washed three times and centrifuged at the cell
number 1 × 103. The cell plates were scanned using 1.5T
MR system. Under T2 weighted MR images of MC-IONPs
were obtained with 1.5T MR system (Medius Co. Korea,
Model Magnum1.5T) by using a spin echo technique. The
differences between MR images of cells with and without
MC-IONPs incubation were compared.
Abbreviations
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modified chitosan;
MRI: Magnetic resonance imaging;
IOPs: Iron oxide nanoparticles).
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